Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Dexmedetomidine and Perioperative Intestinal Function in Spine Surgery
ChiCTR1800018127Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in lumbar spondylolisthesis (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Postoperative intestinal exhaust time. Started Sep 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
lumbar spondylolisthesis
Beyond the preview
Go deeper on ChiCTR1800018127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018127.